Tumorigenesis in the multiple intestinal neoplasia mouse: Redundancy of negative regulators and specificity of modifiers

被引:115
作者
Halberg, RB
Katzung, DS
Hoff, PD
Moser, AR
Cole, CE
Lubet, RA
Donehower, LA
Jacoby, RF
Dove, WF
机构
[1] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA
[2] Univ Wisconsin, Dept Biostat, Madison, WI 53706 USA
[3] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA
[4] Univ Wisconsin, Ctr Comprehens Canc, Madison, WI 53792 USA
[5] NCI, Chemoprevent Branch, Div Canc Prevent, Bethesda, MD 20892 USA
[6] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA
[7] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
关键词
D O I
10.1073/pnas.050585597
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The interaction between mutations in the tumor-suppressor genes Ape and p53 was studied in congenic mouse strains to minimize the influence of polymorphic modifiers. The multiplicity and invasiveness of intestinal adenomas of Apc(Min/+) (Min) mice was enhanced by deficiency for p53, In addition, the occurrence of desmoid fibromas was strongly enhanced by p53 deficiency. The genetic modifier Mom1 and the pharmacological agents piroxicam and difluoromethylornithine each reduced intestinal adenoma multiplicity in the absence of p53 function. Mom1 showed no influence on the development of desmoid fibromas, whereas the combination of piroxicam and difluoromethylornithine exerted a moderate effect, The ensemble of tumor suppressors and modifiers of a neoplastic process can be usefully analyzed in respect to tissue specificity and synergy.
引用
收藏
页码:3461 / 3466
页数:6
相关论文
共 40 条
[11]  
Fodde Riccardo, 1995, Critical Reviews in Oncogenesis, V6, P291
[12]   In vivo targeted mutagenesis of a regulatory element required for positioning the Hoxd-11 and Hoxd-10 expression boundaries [J].
Gerard, M ;
Chen, JY ;
Gronemeyer, H ;
Chambon, P ;
Duboule, D ;
Zakany, J .
GENES & DEVELOPMENT, 1996, 10 (18) :2326-2334
[13]  
Gould KA, 1996, GENETICS, V144, P1769
[14]  
Gould KA, 1996, GENETICS, V144, P1777
[15]   A MUTANT P53 TRANSGENE ACCELERATES TUMOR-DEVELOPMENT IN HETEROZYGOUS BUT NOT NULLIZYGOUS P53 DEFICIENT MICE [J].
HARVEY, M ;
VOGEL, H ;
MORRIS, D ;
BRADLEY, A ;
BERNSTEIN, A ;
DONEHOWER, LA .
NATURE GENETICS, 1995, 9 (03) :305-311
[16]   PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs [J].
He, TC ;
Chan, TA ;
Vogelstein, B ;
Kinzler, KW .
CELL, 1999, 99 (03) :335-345
[17]  
JACOBY RF, 2000, IN PRESS CANC RES
[18]  
KINZLER KW, 1998, GENETIC BASIS HUMAN, P241
[19]  
KNUDSON AG, 1978, SEMIN ONCOL, V5, P57